At the annual AWS Life Sciences Executive Symposium, the company announced new Amazon Omics capabilities to help customers build, run and scale 35 Ready2Run workflows by Element Biosciences, NVIDIA and Sentieon Inc.
WHY IT MATTERS
Large-scale analysis omics data typically requires specialized…
From: www.healthcareitnews.com – Read more
Will Expanding to Life Sciences Reverse AMD’s Stock Decline?
AMD announced its first life sciences collaboration with AI-based drug developer Absci, providing its hardware and software for Absci’s AI drug discovery. Despite AMD also